Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
Saved in:
| Title: | Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. |
|---|---|
| Authors: | Eslinger C; Department of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Sonbol MB; Department of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., George B; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Babiker H; Department of Hematology-Oncology, Mayo Clinic, Jacksonville, FL, USA., Borad MJ; Department of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Bekaii-Saab TS; Department of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2026 Mar 27; Vol. 20, pp. 559325. Date of Electronic Publication: 2026 Mar 27 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1177-8881 |
|---|---|
| DOI: | 10.2147/DDDT.S559325 |
